glp-1 management platform startups Agonists Market Report 2025-2033, By Product, Molecule, and Geo What's next for GLP-1 innovation:

Your coach will guide you every step of the way, helping you seamlessly integrate healthy habits into your current lifestyle

The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI)

According to the literature, the prevalence of depression is significantly higher in patients with type 2 diabetes than in those without diabetes (17.6% vs

GLP-1 drugs and healthy habits work together to boost heart health, Harvard study confirms Patients with type 2 diabetes who use GLP-1 receptor agonists (GLP-1 RAs) and make healthy lifestyle choices can significantly lower their risk of experiencing a heart attack or stroke, according to new data published in The Lancet Diabetes & Endocrinology .[1] The studys authors explored data from more than 98,000 participants from the U.S